Why Aurinia Pharmaceuticals Stock Briefly Spiked Today
Shares of commercial-stage autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) raced higher in early action Thursday morning, rising as much as 15.7%. Why did investors bid up Aurinia's shares?